Skip to main content
SpringerLink
Log in

Tryptophan-Metabolismus bei Lebererkrankungen: Eine pharmakokinetische und enzymatische Untersuchung

Tryptophan-metabolism in liver disease: A pharmacokinetic and enzymatic study

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Tryptophan is considered to be one of the agents involved in the pathogenesis of hepatic encephalopathy. In our study, we evaluated tryptophan metabolism in liver disease. A bolus of 1.5 g ofl-tryptophan was administered intravenously to 14 patients with noncirrhotic liver disease, 40 patients with liver cirrhosis, and 8 healthy volunteers. As pharmacokinetic parameters, the half life, clearance, and volume of distribution of free and total tryptophan were determined using a biexponential formula. In addition, the activity of liver tryptophan pyrrolase, the key enzyme of tryptophan metabolism, was measured in liver biopsy specimens of 15 patients with noncirrhotic liver disease, 8 patients with cirrhosis of the liver, and 4 patients with histologically normal livers.

Healthy subjects and patients with noncirrhotic liver disease both showed similar results in measured and calculated data. In contrast, patients with cirrhosis revealed significant alterations of the pharmacokinetic parameters of free and total tryptophan: the half-life was increased by 195% and 176%, the clearance was decreased by 73% and 34%, respectively, and the activity of tryptophan pyrrolase was decreased by 22%. The tryptophan transfer in cirrhosis amounted to only 0.75±0.03 g per 24 h compared with 2.6±0.34 g per 24 h in healthy individuals. The findings demonstrate that patients with cirrhosis show a marked reduction in their ability to metabolize tryptophan. This should be taken into account in the oral and parenteral nutrition of those patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Aslanin IG (1966) Tryptophan pyrrolase in kidney. Dokl Akad Nauk Arm SSR 43:215

    Google Scholar 

  2. Badawy AAB, Evans M (1975) The regulation of rat liver tryptophan pyrrolase by its cofactor haem, experiments with haematin and 5-amino-laevulinate and comparison with the substrate and hormonal mechanisms. Biochem J 150:511–520

    Google Scholar 

  3. Badawy AAB, Evans M (1976) Animal liver pyrrolase, absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicity. Biochem J 158:79–88

    Google Scholar 

  4. Badawy AAB, Punjani NF, Evans M (1979) Enhancement of rat brain tryptophan metabolism by chronic ethanol administration and possible involvement of decreased liver tryptophan pyrrolase activity. Biochem J 178:575–580

    Google Scholar 

  5. Badawy AAB, Punjani NF, Evans M (1981) The role of liver tryptophan pyrrolase in the opposite effects of chronic administration and subsequent withdrawal of drugs of dependence on rat brain tryptophan metabolism. Biochem J 196:161–170

    Google Scholar 

  6. Blaschke TF (1977) Protein binding and kinetics of drug in liver disease. Clin Pharmakokinetics 2:32–44

    Google Scholar 

  7. Bloxam DL, Warren WH (1974) Error in the determination of tryptophan by the method of Denckla and Dewey. A revised procedure. Anal Biochem 60:621–625

    Google Scholar 

  8. Cummings MG, Soeters PB, James JH, Fischer JE (1976) Regional brain indoleamine metabolism following chronic portacaval anastomosis in the rat. J Neurochem 27:501–509

    Google Scholar 

  9. Curzon G, Friedel J, Knott PJ (1973a) The effects of fatty acids on binding of tryptophan to plasma proteins. Nature (London) 242:198

    Google Scholar 

  10. Curzon G, Kantamaneni BD, Winch J, Rojas-Bueno A, Murray-Lyon IM, Williams R (1973b) Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem 21:137–145

    Google Scholar 

  11. Curzon G, Knott PJ (1974) Fatty acids and the disposition of tryptophan. In: Wolstenholme GE, Fitzsimons DW (eds) Aromatic amino acids in the brain, Ciba Foundation symp 22. Elsevier, Excerpta Medica, North Holland, p 217

    Google Scholar 

  12. Curzon G, Knott PJ (1975a) Rapid effects of environmental disturbance on rat plasma unesterified fatty acid and their prevention by antilipolytic drugs. Br J Pharmacol 54:389

    Google Scholar 

  13. Curzon G, Kantamaneni BD, Fernando JC, Woods MS, Cavanagh JB (1975b) Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem 24:1065–1070

    Google Scholar 

  14. Fischer JE (1982) Amino acids in hepatic coma. Dig Dis Sci 27:97–102

    Google Scholar 

  15. Friedman PA, Kappelman AH, Kaufman S (1972) Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem 247:4165

    Google Scholar 

  16. Gal EM (1974) Cerebral tryptophan-2,3-dioxygenase (pyrrolase) and its induction in rat brain. J Neurochem 22:861

    Google Scholar 

  17. James HJ, Hodgeman JM, Funovics JM, Yoshimura N, Fischer JE (1976) Brain tryptophan, plasma free tryptophan and distribution of plasma neutral amino acids. Metabolism 25:471

    Google Scholar 

  18. Knell AJ, Davidson AR, Williams R, Kantamaneni BD, Curzon G (1974) Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J 1:549–551

    Google Scholar 

  19. Leklem JE (1971) Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am J Clin Nutr 24:659–672

    Google Scholar 

  20. Motoni F, Cara V, Lombardi G, Pellegrini D, Larassale GL, Cortesini C (1984) Excitatory amino acids, tryptophan metabolism, and endogenous neurotoxicity in porta-caval shunted rats. In: Kleineberger G, Ferenci P, Riederer P, Thaler H (eds) Advances in hepatic encephalopathy and urea cycle diseases. Karger, München

    Google Scholar 

  21. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R (1978) Tryptophan and hepatic coma. Gastroenterology 74:196–200

    Google Scholar 

  22. Pant KC, Roger QR, Harper AE (1965) Studies of amino acid imbalance involving tryptophan. Fed Proc 24:316

    Google Scholar 

  23. Pardridge WM (1979) Tryptophan transport through the blood-brain barrier: in vivo measurement of free and albuminbound amino acid. Life Sciences 25:1519–1528

    Google Scholar 

  24. Rössle M, Luft M, Herz R, Klein B, Lehmann M, Gerok W (1984) Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution. Klin Wochenschr 62:867–875

    Google Scholar 

  25. Rössle M (1985) Tryptophan-Pharmakokinetik. Hepatische Tryptophan-Extraktion bei Normalpersonen und bei der perfundierten Rattenleber. In: Kleinberger G, Bürger U (eds) Aminosäuren-Transferlösungen. (Klinische Ernährung 15) Zuckschwerdt, München Bern Wien, S 133–136

    Google Scholar 

  26. Smith AR, Rossi-Fanelli F, James JH, Perelle BA, Fischer JE (1978) Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 187:343–350

    Google Scholar 

  27. Tagliamonte A, Biggio G, Gessa GL (1971) Possible role of “free” plasma tryptophan in controlling brain tryptophan concentrations. Riv Farmacol Ter 2:251

    Google Scholar 

  28. Vilstrup H, Bucher D, Krog B, Damgard SE (1982) Elimination of infused amino acids from plasma of control subjects and of patients with cirrhosis of the liver. Europ J Clin Invest 12:197–202

    Google Scholar 

  29. Weber LJ, Horita AA (1965) A study of 5-hydroxytryptamine formation from L-tryptophan in the brain and other tissues. Biochem Pharmacol 14:1141

    Google Scholar 

  30. Yamamoto S, Hayaishi O (1967) Tryptophan pyrrolase of rabbit intestine. J Biol Chem 242:5260

    Google Scholar 

  31. Yoshida K, Hirayama C (1980) Clinical evaluation of serum levels of tryptophan in hepatobiliary disease. Clin Chim Acta 101:235–240

    Google Scholar 

  32. Zoli M, Marchesini G, Cecchini L, Dondi C, Bianchi FB, Pisi E (1981) Binding of tryptophan to albumin in liver cirrhosis: a reappraisal of the problem. Hepato-Gastroenterology 28:87–89

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Universitätsklinik, Freiburg

    M. Rössle, R. Herz, B. Klein & W. Gerok

  2. National Institute of Health, Building 10, Room 4D52, 20892, Bethesda, MD, USA

    M. Rössle

Authors
  1. M. Rössle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Herz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Gerok
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rössle, M., Herz, R., Klein, B. et al. Tryptophan-Metabolismus bei Lebererkrankungen: Eine pharmakokinetische und enzymatische Untersuchung. Klin Wochenschr 64, 590–594 (1986). https://doi.org/10.1007/BF01735261

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01735261

Key words

Search

Navigation